Content area
Full Text
Peng Gao [] and Zhenzhong Su [] and Xuejiao Lv [] and Jie Zhang [] and []
Academic Editor: Tânia Silvia Fröde
Department of Respiratory Medicine, The Second Affiliated Hospital of Jilin University, Changchun, China, jlu.edu.cn
Received Feb 13, 2017; Accepted Mar 26, 2017
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. Introduction
Interleukin- (IL-) 35 is a member of the IL-12 cytokine family [1, 2] and was first described almost two decades ago as a heterodimer formed by the subunits Epstein-Barr-induced gene 3 (EBI3) and IL-12p35. It was found in the trophoblast component of the human placenta and suggested to be an important immunoregulator already upon discovery [3]. IL-35 induces the generation of a unique class of IL-35-producing regulatory T cells (Tregs) that are distinctly different from the other transforming growth factor beta- (TGF-
The IL-35 receptors on the cell surface can be either homodimers of IL-12R
[figure...